Skip to main content
Jose Leone, MD, Oncology, Boston, MA

JosePabloLeoneMD

Oncology • Boston, MA

Breast Cancer, Hematologic Oncology

Assistant Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Leone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leone's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215

Summary

  • Dr. Jose Leone is an oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Dana-Farber Cancer Institute and Brigham and Women's Hospital. He received his medical degree from University of Salvador Faculty of Medicine and has been in practice 12 years. He also speaks multiple languages, including Spanish. He specializes in breast cancer and hematologic oncology and is experienced in male breast cancer.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
  • Univ Salvador- Fac Med
    Univ Salvador- Fac MedClass of 2005

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2017 - 2026
  • IA State Medical License
    IA State Medical License 2014 - 2018
  • PA State Medical License
    PA State Medical License 2011 - 2014
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy: A Breast International Group (BIG) 1-98 sub-analyses. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Factors associated with twenty-year (y) risks of breast cancer-specific mortality (BCSM) in the Surveillance, Epidemiology, and End Results (SEER) Registry. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Clinical Challenges: Diagnosing and Treating Male Breast Cancer
    Clinical Challenges: Diagnosing and Treating Male Breast CancerDecember 29th, 2022
  • The Pink Ribbon of Breast Cancer Awareness Needs a Splash of Blue for Men
    The Pink Ribbon of Breast Cancer Awareness Needs a Splash of Blue for MenOctober 28th, 2023

Professional Memberships

Other Languages

  • Spanish

Dr. Jose Leone, Dr. Jose Leone, MD, Dr. J Leone, Dr. Jose Pablo Leone